{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:06:54Z","timestamp":1791421614633,"version":"4.3.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T00:00:00Z","timestamp":1348790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10792-012-9634-1","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T18:16:56Z","timestamp":1348769816000},"page":"39-46","source":"Crossref","is-referenced-by-count":69,"title":["Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial"],"prefix":"10.1007","volume":"33","author":[{"given":"Nader","family":"Baharivand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mahdavifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohollah Fadaei","family":"Fouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,28]]},"reference":[{"key":"9634_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9394(14)74217-5","volume":"103","author":"DE Henderly","year":"1987","unstructured":"Henderly DE, Genstler AJ, Smith RE et al (1987) Changing patterns of uveitis. Am J Ophthalmol 103:131\u2013136","journal-title":"Am J Ophthalmol"},{"key":"9634_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004397-199503520-00004","volume":"35","author":"KF Tabbara","year":"1995","unstructured":"Tabbara KF (1995) Ocular toxoplasmosis: toxoplasmic retinochoroiditis. Int Ophthalmol Clin 35:15\u201329","journal-title":"Int Ophthalmol Clin"},{"key":"9634_CR3","volume-title":"Focal points: clinical modules for ophthalmologists","author":"American Academy of Ophthalmology","year":"2011","unstructured":"American Academy of Ophthalmology (2011) Focal points: clinical modules for ophthalmologists. American Academy of Ophthalmology, San Francisco"},{"key":"9634_CR4","volume-title":"Uveitis: fundamentals in clinical practice","author":"RB Nussenblatt","year":"1995","unstructured":"Nussenblatt RB, Whitcup SM, Palestine AG (1995) Uveitis: fundamentals in clinical practice. Mosby, St. Louis"},{"key":"9634_CR5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9394(14)73706-7","volume":"111","author":"RE Engstrom Jr","year":"1991","unstructured":"Engstrom RE Jr, Holland GN, Nussenblatt RB et al (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111:601\u2013610","journal-title":"Am J Ophthalmol"},{"key":"9634_CR6","first-page":"140","volume":"11","author":"MS Wertheim","year":"2004","unstructured":"Wertheim MS, Smith JR, Cunningham ET et al (2004) Toxoplasmosis can test diagnostic skills. Rev Ophthalmol 11:140","journal-title":"Rev Ophthalmol"},{"key":"9634_CR7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","volume":"115","author":"A Rothova","year":"1993","unstructured":"Rothova A, Meenken C, Buitenhuis HJ et al (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115:517\u2013523","journal-title":"Am J Ophthalmol"},{"key":"9634_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","volume":"134","author":"LH Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MS et al (2002) A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol 134:34\u201340","journal-title":"Am J Ophthalmol"},{"key":"9634_CR9","first-page":"95","volume":"13","author":"JG Ferguson Jr","year":"1981","unstructured":"Ferguson JG Jr (1981) Clindamycin therapy for toxoplasmosis. Ann Ophthalmol 13:95\u2013100","journal-title":"Ann Ophthalmol"},{"key":"9634_CR10","doi-asserted-by":"crossref","unstructured":"Martinez CE, Zhang D, Conway MD et al (1998\u20131999) Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int Ophthalmol 22:85\u201388","DOI":"10.1023\/A:1006129422690"},{"key":"9634_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","volume":"118","author":"M Soheilian","year":"2011","unstructured":"Soheilian M, Ramezani A, Azimzadeh A et al (2011) Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology 118:134\u2013141","journal-title":"Ophthalmology"},{"key":"9634_CR12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ajo.2008.09.006","volume":"146","author":"EM Dodds","year":"2008","unstructured":"Dodds EM, Holland GN, Stanford MR et al (2008) Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol 146:856\u2013865","journal-title":"Am J Ophthalmol"},{"key":"9634_CR13","volume-title":"Clinical ophthalmology: a systematic approach","author":"JJ Kanski","year":"2007","unstructured":"Kanski JJ (2007) Clinical ophthalmology: a systematic approach. Butterworth\u2013Heinemann, Oxford"},{"key":"9634_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9394(14)78240-6","volume":"47","author":"SJ Kimura","year":"1959","unstructured":"Kimura SJ, Thygeson P, Hogan M (1959) Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis. Am J Ophthalmol 47:171\u2013176","journal-title":"Am J Ophthalmol"},{"key":"9634_CR15","first-page":"58","volume":"28","author":"S Lam","year":"1993","unstructured":"Lam S, Tessler HH (1993) Quadruple therapy for ocular toxoplasmosis. Can J Ophthalmol 28:58\u201361","journal-title":"Can J Ophthalmol"},{"key":"9634_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1755-3768.1983.tb01394.x","volume":"61","author":"H Guldsten","year":"1983","unstructured":"Guldsten H (1983) Clindamycin and sulphonamides in the treatment of ocular toxoplasmosis. Acta Ophthalmol (Cph) 61:51\u201357","journal-title":"Acta Ophthalmol (Cph)"},{"key":"9634_CR17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1974.01010010252017","volume":"92","author":"KF Tabbara","year":"1974","unstructured":"Tabbara KF, Nozik RA, O\u2019Connor GR (1974) Clindamycin effects on experimental ocular toxoplasmosis in the rabbit. Arch Ophthalmol 92:244\u2013247","journal-title":"Arch Ophthalmol"},{"key":"9634_CR18","volume-title":"Text book of ocular pharmacology","author":"TJ Zimmerman","year":"1997","unstructured":"Zimmerman TJ, Kooner KS, Sharir M, Fechtner RD (1997) Text book of ocular pharmacology. Lippincott Williams & Wilkins, Philadelphia"},{"key":"9634_CR19","first-page":"296","volume":"14","author":"R Norrby","year":"1978","unstructured":"Norrby R (1978) A review of the penetration of antibiotics into CSF and its clinical significance. Scand J Infect Dis Suppl 14:296\u2013309","journal-title":"Scand J Infect Dis Suppl"},{"key":"9634_CR20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/133.5.578","volume":"133","author":"GT Keusch","year":"1976","unstructured":"Keusch GT, Present DH (1976) Summary of a workshop on clindamycin colitis. J Infect Dis 133:578\u2013587","journal-title":"J Infect Dis"},{"key":"9634_CR21","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1007\/BF01639009","volume":"7","author":"DS Reeves","year":"1979","unstructured":"Reeves DS, Wilkinson PJ (1979) The pharmacokinetics of trimethoprim and trimethoprim\/sulphonamide combinations, including penetration into body tissues. Infection 7:S330\u2013S341","journal-title":"Infection"},{"key":"9634_CR22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/infdis\/157.3.580","volume":"157","author":"LM Weiss","year":"1988","unstructured":"Weiss LM, Harris C, Berger M et al (1988) Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS. J Infect Dis 157:580\u2013583","journal-title":"J Infect Dis"},{"key":"9634_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-9394(61)90741-3","volume":"52","author":"HE Kaufman","year":"1961","unstructured":"Kaufman HE (1961) The penetration of daraprim (pyrimethamine) into the monkey eye. Am J Ophthalmol 52:402\u2013404","journal-title":"Am J Ophthalmol"},{"key":"9634_CR24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","volume":"22","author":"C Katlama","year":"1996","unstructured":"Katlama C, De Wit S, O\u2019Doherty E et al (1996) Pyrimethamine\u2013clindamycin vs. pyrimethamine\u2013sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 22:268\u2013275","journal-title":"Clin Infect Dis"},{"key":"9634_CR25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJM199309303291403","volume":"329","author":"BJ Luft","year":"1993","unstructured":"Luft BJ, Hafner R, Korzun AH et al (1993) Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 329:995\u20131000","journal-title":"N Engl J Med"},{"key":"9634_CR26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9394(64)91214-0","volume":"58","author":"NA Wine","year":"1964","unstructured":"Wine NA, Gornall AG, Basu PK (1964) The ocular uptake of subconjunctivally injected C14 hydrocortisone. 1. Time and major route of penetration in a normal eye. Am J Ophthalmol 58:362\u2013366","journal-title":"Am J Ophthalmol"},{"key":"9634_CR27","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0181-5512(05)81121-0","volume":"28","author":"Z Benzina","year":"2005","unstructured":"Benzina Z, Chaabouni S, Hentati N et al (2005) Recurrent toxoplasmic retinochoroiditis after clindamycin treatment. J Fr Ophtalmol 28:958\u2013964","journal-title":"J Fr Ophtalmol"},{"key":"9634_CR28","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archopht.1975.01010020882011","volume":"93","author":"KF Tabbara","year":"1975","unstructured":"Tabbara KF, O\u2019Connor GR (1975) Ocular tissue absorption of clindamycin phosphate. Arch Ophthalmol 93:1180\u20131185","journal-title":"Arch Ophthalmol"},{"key":"9634_CR29","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/AAC.39.7.1530","volume":"39","author":"ME Fichera","year":"1995","unstructured":"Fichera ME, Bhopale MK, Roos DS (1995) In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrob Agents Chemother 39:1530\u20131537","journal-title":"Antimicrob Agents Chemother"},{"key":"9634_CR30","volume-title":"Intravitreal surgery: principles and practice","author":"GA Peyman","year":"1994","unstructured":"Peyman GA, Schulman JA (1994) Intravitreal surgery: principles and practice. Appleton & Lange, Norwalk"},{"key":"9634_CR31","volume-title":"Vitreoretinal surgical techniques","author":"GA Peyman","year":"2001","unstructured":"Peyman GA, Meffert SA, Chou F, Conway MD (2001) Vitreoretinal surgical techniques. Taylor & Francis, London"},{"key":"9634_CR32","volume-title":"Endophthalmitis: diagnosis and management","author":"PJ Lee","year":"2004","unstructured":"Lee PJ, Seal DV, Peyman GA (2004) Endophthalmitis: diagnosis and management. Informa Healthcare, London"},{"key":"9634_CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0002-9394(80)90108-7","volume":"89","author":"RB Nussenblatt","year":"1980","unstructured":"Nussenblatt RB, Gery I, Ballintine EJ et al (1980) Cellular immune responsiveness of uveitis patients to retinal S-antigen. Am J Ophthalmol 89:173\u2013179","journal-title":"Am J Ophthalmol"},{"key":"9634_CR34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0002-9394(82)90418-4","volume":"93","author":"IW Abrahams","year":"1982","unstructured":"Abrahams IW, Gregerson DS (1982) Longitudinal study of serum antibody responses to retinal antigens in acute ocular toxoplasmosis. Am J Ophthalmol 93:224\u2013231","journal-title":"Am J Ophthalmol"},{"key":"9634_CR35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/bjo.82.9.1017","volume":"82","author":"RM Whittle","year":"1998","unstructured":"Whittle RM, Wallace GR, Whiston RA et al (1998) Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 82:1017\u20131021","journal-title":"Br J Ophthalmol"},{"key":"9634_CR36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3928\/1542-8877-20010501-03","volume":"32","author":"K Kishore","year":"2001","unstructured":"Kishore K, Conway MD, Peyman GA (2001) Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers 32:183\u2013192","journal-title":"Ophthalmic Surg Lasers"},{"key":"9634_CR37","first-page":"34","volume":"5","author":"JT Pague","year":"1974","unstructured":"Pague JT, Peyman GA (1974) Intravitreal clindamycin phosphate in the treatment of vitreous infection. Ophthalmic Surg 5:34\u201339","journal-title":"Ophthalmic Surg"},{"key":"9634_CR38","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/IAE.0b013e31804b3f0d","volume":"27","author":"L Sobrin","year":"2007","unstructured":"Sobrin L, Kump LI, Foster CS (2007) Intravitreal clindamycin for toxoplasmic retinochoroiditis. Retina 27:952\u2013957","journal-title":"Retina"},{"key":"9634_CR39","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","volume":"112","author":"M Soheilian","year":"2005","unstructured":"Soheilian M, Sadoughi MM, Ghajarnia M et al (2005) Prospective randomized trial of trimethoprim\/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 112:1876\u20131882","journal-title":"Ophthalmology"},{"key":"9634_CR40","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ophtha.2010.01.028","volume":"117","author":"AF Lasave","year":"2010","unstructured":"Lasave AF, D\u00edaz-Llopis M, Muccioli C et al (2010) Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months. Ophthalmology 117:1831\u20131838","journal-title":"Ophthalmology"},{"key":"9634_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/B:INTE.0000006768.66170.c1","volume":"24","author":"M Soheilian","year":"2001","unstructured":"Soheilian M, Rafati N, Peyman GA (2001) Prophylaxis of acute posttraumatic bacterial endophthalmitis with or without combined intraocular antibiotics: a prospective, double-masked randomized pilot study. Int Ophthalmol 24:323\u2013330","journal-title":"Int Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9634-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-012-9634-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-012-9634-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T17:54:04Z","timestamp":1643478844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-012-9634-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9634"],"URL":"https:\/\/doi.org\/10.1007\/s10792-012-9634-1","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,28]]}}}